Biomarker development for PCOS diagnosis
DOI:
https://doi.org/10.47611/jsrhs.v12i2.4267Keywords:
Polycystic Ovary Syndrome, PCOS, Polycystic ovarian syndrome, BiomarkersAbstract
Polycystic Ovary Syndrome, most commonly known as PCOS, is a condition that affects at least 6 million women of reproductive age in the United States alone. Approximately 10% of women worldwide are affected by PCOS as it is the number one cause of female infertility. Diagnosis of PCOS is not a process that has been fully coagulated as many of the symptoms overlap with many other conditions. Biomarker development to diagnose PCOS during the earlier stages is critical to making advancements in the field as earlier detection means more time to treat the symptoms and possibly find a treatment.
Downloads
References or Bibliography
Daan, N. M. P., Koster, M. P. H., Wilde, M. A. de, Dalmeijer, G. W., Evelein, A. M. V., Fauser, B. C. J. M., & Jager, W. de. (2016, November 2). Biomarker profiles in women with PCOS and PCOS offspring; a pilot study. PLOS ONE. Retrieved December 31, 2022, from https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0165033
DK;, M. (1988, December). Steroidogenesis in human polycystic ovary. Endocrinology and metabolism clinics of North America. Retrieved December 31, 2022, from https://pubmed.ncbi.nlm.nih.gov/3143567/
J;, H. D. M. A. J. L. (2013, November). Decreased myo-inositol to chiro-inositol (m/c) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocrine journal. Retrieved December 31, 2022, from https://pubmed.ncbi.nlm.nih.gov/24189751/
Luo P;Zhang C;He Y;Yang G;Liu H;Li L; (2019). Several circulating biomarkers for PCOS diagnosis. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. Retrieved December 31, 2022, from https://pubmed.ncbi.nlm.nih.gov/31683329/
Na, Z., Guo, W., Song, J., Feng, D., Fang, Y., & Li, D. (2022, July 6). Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome - journal of ovarian research. BioMed Central. Retrieved December 31, 2022, from https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-022-01013-0#:~:text=The%20two%20diagnostic%20biomarkers%20of,was%20consistent%20with%20bioinformatics%20results.
Raja-Khan N;Kunselman AR;Demers LM;Ewens KG;Spielman RS;Legro RS; (2010, December). A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome. Fertility and sterility. Retrieved December 31, 2022, from https://pubmed.ncbi.nlm.nih.gov/20630504/
Ramírez Martín, N., Romeu, M., Martínez, J., Peinado, I., Buigues, A., Marchante, M., Pellicer, A., & Herraiz, S. (2022, June 30). P-652 contribution of the D19S884 allele 8 of the FBN3 gene and the Hippo signaling to the reproductive and metabolic phenotype of PCOS patients. OUP Academic. Retrieved December 31, 2022, from https://academic.oup.com/humrep/article/37/Supplement_1/deac107.601/6620415
Rosenfield, R. L., & Ehrmann, D. A. (2016, October). The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine reviews. Retrieved December 31, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045492/
S;, K. M. J. U. A. B. (2019, December). Genetic basis of polycystic ovary syndrome (PCOS): Current Perspectives. The application of clinical genetics. Retrieved December 31, 2022, from https://pubmed.ncbi.nlm.nih.gov/31920361/
S;, P. (2018, September). Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. The Journal of steroid biochemistry and molecular biology. Retrieved December 31, 2022, from https://pubmed.ncbi.nlm.nih.gov/29678491/
S;, P. K. S. G. H. I. M. (2022, March). Compromised cumulus-oocyte complex matrix organization and expansion in women with PCOS. Reproductive sciences (Thousand Oaks, Calif.). Retrieved December 31, 2022, from https://pubmed.ncbi.nlm.nih.gov/34748173/
Shafiee, M. N., Ortori, C. A., Barrett, D. A., Mongan, N. P., Abu, J., & Atiomo, W. (2020, July 3). Lipidomic biomarkers in polycystic ovary syndrome and endometrial cancer. International journal of molecular sciences. Retrieved December 31, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370092/
Published
How to Cite
Issue
Section
Copyright (c) 2023 Joshitha Senthil
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
